Published in Pediatr Res on November 01, 1984
Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three. Infect Immun (1992) 1.26
Neonatal innate immunity to infectious agents. Infect Immun (2006) 1.11
Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect Immun (2006) 0.99
Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J Allergy Clin Immunol (2012) 0.90
Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev (2008) 0.84
Novel microtechnique for assessment of postnatal maturation of the phagocytic function of neutrophils and monocytes. Clin Diagn Lab Immunol (2003) 0.81
Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines. Clin Diagn Lab Immunol (1994) 0.79
Fc gamma RI and Fc gamma RIII on polymorphonuclear leucocytes in cord blood. Arch Dis Child Fetal Neonatal Ed (1994) 0.77
Correlation of susceptibility of immature mice to fungal infection (blastomycosis) and effector cell function. Infect Immun (2000) 0.75
Differential responsiveness of cord and adult blood monocytes to hepatocyte growth factor. Clin Exp Immunol (2001) 0.75
Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults. Clin Diagn Lab Immunol (1996) 0.75
Functions of granulocytes and monocytes in primary biliary and alcoholic cirrhosis. Clin Exp Immunol (1985) 0.75
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res (2016) 0.75
Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity. Am J Reprod Immunol (2017) 0.75
Specialized Pro-resolving Mediators (SPM) Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Re-infection. Infect Immun (2017) 0.75
The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96
Morphology and peroxidase cytochemistry of mouse promonocytes, monocytes, and macrophages. J Exp Med (1970) 4.26
The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 4.25
The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med (1970) 4.09
Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. J Exp Med (1979) 3.57
Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro. J Exp Med (1975) 3.53
Nitric oxide: a predictor of morbidity in postoperative patients? Lancet (1994) 3.26
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
The kinetics of promonocytes and monocytes in the bone marrow. J Exp Med (1970) 3.12
Origin and kinetics of monocytes and macrophages. Semin Hematol (1970) 2.92
The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity. Immunology (1966) 2.83
Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax (1995) 2.54
The immunological development of the human fetus. J Exp Med (1965) 2.44
Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest (1979) 2.42
The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions. Immunology (1966) 2.40
The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med (1978) 2.29
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
The effect of glucocorticosteroids on the proliferation and kinetics of promonocytes and monocytes of the bone marrow. J Exp Med (1973) 2.01
Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol (1987) 1.92
Characteristics of human mononuclear phagocytes. Blood (1979) 1.88
Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis (1992) 1.86
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology (1979) 1.73
High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis (1995) 1.70
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother (1989) 1.66
In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology (1975) 1.64
Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS (1994) 1.61
In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med (1982) 1.56
Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol (1980) 1.55
Origin and turnover of monocytes and macrophages. Curr Top Pathol (1989) 1.54
The formation of immunoglobulins by human tissues in vitro. 3. Spleen, lymph nodes, bone marrow and thymus. Immunology (1966) 1.53
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology (1975) 1.50
In vitro synthesis of immunoglobulins, secretory component and complement in normal and pathological skin and the adjacent mucous membranes. Clin Exp Immunol (1973) 1.50
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis (1981) 1.48
Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis. Br J Dermatol (2014) 1.46
Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes. Proc Natl Acad Sci U S A (1988) 1.46
CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol (1991) 1.45
Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium. Biotherapy (1994) 1.42
Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes. Ann N Y Acad Sci (1976) 1.41
Effect of warfarin on the induction and course of experimental endocarditis. Infect Immun (1976) 1.40
[Bacterial meningitis; pathogenesis and current possibilities of additional therapy]. Ned Tijdschr Geneeskd (1992) 1.40
Monocyte adherence to human vascular endothelium. J Leukoc Biol (1993) 1.38
Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun (1998) 1.38
[Immune response following preventive intracutaneous rabies vaccination]. Ned Tijdschr Geneeskd (1991) 1.38
Exclusive occurrence of K chains in isolated cold haemagglutinins. Scand J Haematol (1965) 1.38
Low-dose versus high-frequency regimens in Gaucher's disease. Lancet (1995) 1.38
Functions of phagocytic cells in chronic mucocutaneous candidiasis. Br Med J (1978) 1.37
Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol (1999) 1.35
Current view on the mononuclear phagocyte system. Immunobiology (1982) 1.35
Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun (1990) 1.32
Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol (1997) 1.31
Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J Immunol (1987) 1.31
IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. Immunology (1987) 1.30
Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis (1993) 1.29
Dual origin of mouse spleen macrophages. J Exp Med (1984) 1.28
Kinetics of phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes. Scand J Immunol (1981) 1.27
Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect Immun (1999) 1.27
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun (1994) 1.27
Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect Immun (1992) 1.25
Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. J Cell Sci (1999) 1.25
Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis (1988) 1.25
Culture of mononuclear phagocytes on a teflon surface to prevent adherence. J Exp Med (1978) 1.25
The use of lysostaphin in in vitro assays of phagocyte function: adherence to and penetration into granulocytes. Scand J Immunol (1981) 1.25
Properties of a factor increasing monocytopoiesis (FIM) occurring in serum during the early phase of an inflammatory reaction. Blood (1977) 1.24
The formation of immunoglobulins by human tissues in vitro. II. Quantitative studies. Immunology (1966) 1.23
Suspension cultures of mononuclear phagocytes in the teflon culture bag. Cell Immunol (1979) 1.23
Proliferative characteristics of monoblasts grown in vitro. J Exp Med (1975) 1.22
Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages. Infect Immun (1984) 1.22
Role of granulocytes in experimental Streptococcus sanguis endocarditis. Infect Immun (1982) 1.22
Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine (2000) 1.22
Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology (1987) 1.21
Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect Immun (1995) 1.19
Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun (1996) 1.19
Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intravenous administration of heat-killed bacillus Calmette-Guérin. J Exp Med (1981) 1.19
A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet (1983) 1.19
Ultrastructure of mononuclear phagocytes developing in liquid bone marrow cultures. A study on peroxidatic activity. J Exp Med (1979) 1.17
Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis. Infect Immun (1983) 1.16
The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia. Br J Haematol (1966) 1.15
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J Infect Dis (1983) 1.13
Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. Vaccine (2000) 1.13
Method to prove investigation of particles by macrophages with light microscopy. Scand J Immunol (1980) 1.12
Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.11
Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. Blood (1977) 1.10
Origin and kinetics of Kupffer cells during an acute inflammatory response. Immunology (1979) 1.10